Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.85+0.04 (+5.13%)
Close on Nov 18, 2026Market cap $109.78MP/E –Yield –
Organogenesis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Organogenesis's operating cash flow for the twelve months ending Jun 30, 2026 was $31.97M. For fiscal 2025 it was -$10.31M, down 172.6% from the year before. The highest annual figure on record is $61.98M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.31M | -172.6% |
| FY2024 | Dec 31, 2024 | $14.21M | -54.0% |
| FY2023 | Dec 31, 2023 | $30.92M | +24.4% |
| FY2022 | Dec 31, 2022 | $24.86M | -59.9% |
| FY2021 | Dec 31, 2021 | $61.98M | +1033.9% |
| FY2020 | Dec 31, 2020 | $5.47M | – |
| FY2019 | Dec 31, 2019 | -$33.53M | – |
| FY2018 | Dec 31, 2018 | -$60.64M | – |
| FY2017 | Dec 31, 2017 | -$3.49M | – |
| FY2016 | Dec 31, 2016 | -$4.87M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$31.65M | – |
| Q1 FY2026 | Mar 31, 2026 | $21.13M | – |
| Q4 FY2025 | Dec 31, 2025 | $39.42M | +260.4% |
| Q3 FY2025 | Sep 30, 2025 | $3.08M | -64.6% |
| Q2 FY2025 | Jun 30, 2025 | -$32.87M | -793.8% |
| Q1 FY2025 | Mar 31, 2025 | -$19.94M | – |
| Q4 FY2024 | Dec 31, 2024 | $10.94M | +3.0% |
| Q3 FY2024 | Sep 30, 2024 | $8.70M | -48.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.74M | -45.2% |
| Q1 FY2024 | Mar 31, 2024 | -$10.16M | – |
| Q4 FY2023 | Dec 31, 2023 | $10.61M | +36.1% |
| Q3 FY2023 | Sep 30, 2023 | $16.73M | +206.9% |
| Q2 FY2023 | Jun 30, 2023 | $8.65M | -15.2% |
| Q1 FY2023 | Mar 31, 2023 | -$5.08M | -459.8% |
| Q4 FY2022 | Dec 31, 2022 | $7.80M | -56.5% |
| Q3 FY2022 | Sep 30, 2022 | $5.45M | -80.4% |
| Q2 FY2022 | Jun 30, 2022 | $10.20M | -41.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.41M | – |
| Q4 FY2021 | Dec 31, 2021 | $17.95M | -22.7% |
| Q3 FY2021 | Sep 30, 2021 | $27.85M | +214.0% |
| Q2 FY2021 | Jun 30, 2021 | $17.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.30M | – |
| Q4 FY2020 | Dec 31, 2020 | $23.22M | – |
| Q3 FY2020 | Sep 30, 2020 | $8.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$17.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.45M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.12M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.56M | – |
| Q4 FY2018 | Dec 31, 2018 | -$17.41M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.99M | – |
| Q2 FY2018 | Jun 30, 2018 | -$15.78M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.46M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.00M | – |
| Q3 FY2017 | Sep 30, 2017 | -$168.73K | – |
| Q2 FY2017 | Jun 30, 2017 | -$199.74K | – |
| Q1 FY2017 | Mar 31, 2017 | -$126.29K | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.85M | – |
See a number that looks wrong?